Charles Schwab Investment Management Inc Cullinan Oncology, Inc. Transaction History

Charles Schwab Investment Management Inc

$601 Billion
Q3 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 402,638 shares of CGEM stock, worth $3.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

402,638

Previous 435,516 7.55%

Holding current value

$3.44 Million

Previous $3.28 Million 27.2%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$5.93 - $8.34 $194,966 - $274,202	-32,878 Reduced 7.55%	402,638 $2.39 Million
Q2 2025 Aug 12, 2025	BUY	$7.13 - $9.08 $80,241 - $102,186	11,254 Added 2.65%	435,516 $3.28 Million
Q1 2025 Sep 15, 2025	SELL	$7.57 - $12.68 $85,192 - $142,700	-11,254 Reduced 2.58%	424,262 $3.21 Million
Q1 2025 May 09, 2025	SELL	$7.57 - $12.68 $50,787 - $85,070	-6,709 Reduced 1.56%	424,262 $3.21 Million
Q4 2024 Feb 06, 2025	BUY	$10.77 - $17.6 $75,519 - $123,411	7,012 Added 1.65%	430,971 $5.25 Million

Q3 2024 Nov 12, 2024	BUY	$16.03 - $20.86 $854,847 - $1.11 Million	53,328 Added 14.39%	423,959 $7.1 Million
Q2 2024 Aug 12, 2024	BUY	$15.63 - $29.35 $1.76 Million - $3.31 Million	112,758 Added 43.73%	370,631 $6.46 Million
Q1 2024 May 08, 2024	BUY	$10.17 - $19.02 $113,578 - $212,415	11,168 Added 4.53%	257,873 $4.39 Million
Q4 2023 Feb 06, 2024	BUY	$7.89 - $10.23 $131,912 - $171,035	16,719 Added 7.27%	246,705 $2.51 Million
Q3 2023 Nov 08, 2023	BUY	$9.05 - $11.72 $400,010 - $518,024	44,200 Added 23.79%	229,986 $2.08 Million
Q2 2023 Aug 09, 2023	SELL	$8.8 - $13.4 $15,373 - $23,409	-1,747 Reduced 0.93%	185,786 $2 Million
Q1 2023 May 11, 2023	SELL	$10.2 - $11.91 $336,936 - $393,423	-33,033 Reduced 14.98%	187,533 $1.92 Million
Q4 2022 Feb 13, 2023	BUY	$9.72 - $13.62 $29,432 - $41,241	3,028 Added 1.39%	220,566 $2.33 Million
Q3 2022 Nov 14, 2022	BUY	$11.82 - $15.42 $375,462 - $489,816	31,765 Added 17.1%	217,538 $2.79 Million
Q2 2022 Aug 15, 2022	BUY	$7.31 - $13.55 $55,724 - $103,291	7,623 Added 4.28%	185,773 $2.38 Million
Q1 2022 May 13, 2022	BUY	$10.47 - $16.75 $41,220 - $65,944	3,937 Added 2.26%	178,150 $1.87 Million
Q4 2021 Feb 11, 2022	BUY	$15.36 - $25.0 $53,283 - $86,725	3,469 Added 2.03%	174,213 $2.69 Million
Q3 2021 Nov 16, 2021	BUY	$22.56 - $29.68 $1.83 Million - $2.41 Million	81,045 Added 90.35%	170,744 $3.85 Million
Q2 2021 Aug 16, 2021	BUY	$24.96 - $41.25 $81,569 - $134,805	3,268 Added 3.78%	89,699 $2.31 Million
Q1 2021 May 17, 2021	BUY	$28.0 - $53.42 $2.42 Million - $4.62 Million	86,431 New	86,431 $3.6 Million

Others Institutions Holding CGEM

# of Institutions

149

Shares Held

65.1M

Call Options Held

10.7K

Put Options Held

14.4K

View Full List

About Cullinan Oncology, Inc.

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $390M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

More about CGEM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Cullinan Oncology, Inc. Transaction History